|
DNMT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69369979047462E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.20890003247376E-09 |
| Normal-vs-Stage2 |
2.764700E-03 |
| Normal-vs-Stage3 |
2.49299999999231E-05 |
| Normal-vs-Stage4 |
1.99307999999565E-05 |
| Stage1-vs-Stage2 |
5.385400E-01 |
| Stage1-vs-Stage3 |
7.164200E-01 |
| Stage1-vs-Stage4 |
9.289600E-02 |
| Stage2-vs-Stage3 |
8.023600E-01 |
| Stage2-vs-Stage4 |
7.722200E-02 |
| Stage3-vs-Stage4 |
8.022300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14719997337909E-09 |
| Normal-vs-AfricanAmerican |
9.85030000000275E-05 |
| Normal-vs-Asian |
5.490300E-02 |
| Caucasian-vs-AfricanAmerican |
3.753600E-01 |
| Caucasian-vs-Asian |
6.852000E-02 |
| AfricanAmerican-vs-Asian |
2.141400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71940000015525E-08 |
| Normal-vs-Female |
1.47279999307415E-09 |
| Male-vs-Female |
4.286600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.877100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.37940009309534E-10 |
| Normal-vs-Age(61-80Yrs) |
2.02509999991385E-07 |
| Normal-vs-Age(81-100Yrs) |
3.708000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.624600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.284000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.038200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.369800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.525800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.311350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.89349999305477E-09 |
| Normal-vs-Grade 2 |
1.71930000014697E-07 |
| Normal-vs-Grade 3 |
2.2517999997973E-07 |
| Normal-vs-Grade 4 |
2.13279999999871E-05 |
| Grade 1-vs-Grade 2 |
2.877900E-03 |
| Grade 1-vs-Grade 3 |
4.981300E-03 |
| Grade 1-vs-Grade 4 |
4.007600E-01 |
| Grade 2-vs-Grade 3 |
8.921400E-01 |
| Grade 2-vs-Grade 4 |
3.049700E-02 |
| Grade 3-vs-Grade 4 |
3.607600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.54545999999645E-05 |
| Normal-vs-ccB subtype |
3.05719999982301E-07 |
| ccA subtype-vs-ccB subtype |
1.081650E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.57270000040222E-08 |
| Normal-vs-N1 |
4.662600E-03 |
| N0-vs-N1 |
7.490400E-02 |
|
|
